Pharmanza (India) Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.50 Cr
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.17 Cr
- Satisfied Charges ₹ 2.09 Cr
- Revenue Growth 6.42%
- Profit Growth -203.43%
- Ebitda -109.29%
- Net Worth -13.76%
- Total Assets -9.24%
About Pharmanza (India)
Pharmanza (India) Private Limited (PIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 January 2009 and has a history of 16 years and one month. Its registered office is in Anand, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹5.17 Cr. The company has closed loans amounting to ₹2.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hardik Patel, Ravindrabhai Patel, Bhupendrabhai Patel, and Two other members serve as directors at the Company.
Company Details
- Location
Anand, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230GJ2009PTC055895
- Company No.
055895
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Pharmanza (India) Private Limited offer?
Pharmanza (India) Private Limited offers a wide range of products and services, including Herbal Capsules, Ashwagandha Capsules, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Nutritional Supplements, Projector Parts & Peripherals, Dietary Supplements.
Who are the key members and board of directors at Pharmanza (India)?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bhupendrabhai Patel ![]() | Managing Director | 15-Jan-2009 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lal Hingorani ![]() | Director | 15-Jan-2009 | Current |
Hardik Patel ![]() | Whole-Time Director | 15-Jan-2009 | Current |
Ravindrabhai Patel ![]() | Director | 01-Apr-2013 | Current |
Kruti Shah ![]() | Additional Director | Current |
Financial Performance of Pharmanza (India).
Pharmanza (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.42% increase. The company also saw a substantial fall in profitability, with a 203.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.76%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmanza (India)?
In 2023, Pharmanza (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹5.17 Cr
₹2.09 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 5.17 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Aug 2010 | Bank Of India | ₹5.17 Cr | Open |
09 Feb 2018 | Others | ₹2.10 M | Satisfied |
24 Jun 2009 | Indusind Bank Limited | ₹7.25 M | Satisfied |
05 Feb 2009 | The Dharmaj People Cooperative Bank Limited | ₹1.15 Cr | Satisfied |
How Many Employees Work at Pharmanza (India)?
Pharmanza (India) has a workforce of 124 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Pharmanza (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmanza (India)'s trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.